Product helps vaccinate young pigs

A new product on the market makes it possible to vaccinate pigs as young as day one against the serious influenza A virus in swine (IAV-S). With demonstrated efficacy and safety, as well as the flexibility of timing and method of administration, Ingelvac Provenza, Duluth, Georgia, fills an unmet need in the swine industry, and will establish a new way of thinking about influenza protection.

According to Dr. Christa Goodell, DVM, MS, PhD, Dipl ACVPM, technical manager for the Boehringer Ingelheim U.S. Swine Business, “Vaccinating pigs as young as 1-day-old provides protection before pigs are most vulnerable.” Administered intranasally, Ingelvac Provenza provides a direct means of protection at the site of natural IAV-S infection.

Developed and sold by Boehringer Ingelheim, Ingelvac Provenza is the first live attenuated influenza vaccine (LAIV) for growing pigs, offering a new level of protection against the threat of influenza virus strains H1N2 AND H3N2. Live attenuated influenza vaccine has been evaluated to reduce virus shedding in the presence of maternal antibodies.

“Providing game-changing protection when it’s most needed, Ingelvac Provenza offers cross-protection against multiple IAV-S strains and decreases nasal shedding, thereby reducing transmission within the population,” Goodell said.

For more information, see a representative or visit www.IngelvacProvenza.com.